Abdominal tuberculosis (ICD-11 1B12.7) is managed with a full course of antitubercular therapy. Treatment follows a structured, phased approach with defined response monitoring milestones.
Management requires a complete course of antitubercular therapy delivered across two sequential phases — an intensive initial phase and a continuation phase. The specific agents, their combination, and the full duration of each phase are set out in the structured protocol.
Response is assessed weekly during the first 4–6 weeks of treatment. Key indicators include resolution of symptoms, weight gain, and improving haemoglobin alongside a fall in C-reactive protein (CRP) levels.